COMMUNIQUÉS West-GlobeNewswire

Cannara étend son entente d’approvisionnement international avec Curaleaf
05/10/2026
MONTRÉAL, 05 oct. 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. (« Cannara », la « Société », « nous » ou « notre ») ( TSX : LOVE ) ( OTCQX : LOVFF ) ( FRA : 8CB0 ), un producteur verticalement intégré de [...]
AID FOR AIDS and AID FOR LIFE to Celebrate 30 Years of Global Humanitarian Impact at My Hero Gala in New York
05/10/2026
“Dignity Across Borders” Gala Will Honor Edgar Ramírez, Nathalie Rayes, Maria Eugenia Maury and Mary Ann Torres, While Raising Critical Funds for HIV Treatment, Migrant Integration and Earthquake Recovery in Venezuela [...]
Zenflow Secures $52M Series D Financing and Announces Exclusive U.S. Distribution Partnership with Cook Medical
05/10/2026
Series D proceeds to support commercialization of the Zenflow Spring® System for Men with Enlarged Prostate SOUTH SAN FRANCISCO, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Zenflow, Inc., developer of the Zenflow Spring® [...]
Polyrizon Files for U.S. Patent Application to Expand IP Moat Around Intranasal Drug-Delivery Platform
05/10/2026
A new patent application covers Polyrizon’s proprietary mucoadhesive platform and its potential applications in nasal drug delivery. Raanana, Israel, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the [...]
Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors
05/10/2026
Phase 1/2 APOLLO global clinical trial to evaluate CR-002 in multiple solid tumor types, including non-small cell lung cancer (NSCLC) and head and neck squamous cell carcinoma (HNSCC), on track to initiate in the fourth [...]
BBP-418 Demonstrates Potential to Be Disease Modifying Therapy, Restoring Cardiac and Disease Markers to Unaffected Levels
05/10/2026
- In exploratory analyses at Month 12, among individuals with LGMD2I/R9 (FKRP-related) with elevated HS troponin I at baseline, 100% treated with BBP-418 returned to the normal range by Month 12 versus 40% in the [...]
Vireo Growth Inc. Announces Financing for New York and Florida Cultivation Facility
05/10/2026
Transaction supports ownership of key cultivation and production infrastructure in Two Core Markets MINNEAPOLIS, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (CSE: VREO) (OTCQX: VREOF) (“Vireo” or the “Company [...]
FIERCE BIOTECH NAMES REPRONOVO A “FIERCE 15” BIOTECH COMPANY OF 2026
05/10/2026
Lausanne, Switzerland and Copenhagen, Denmark, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Recognition highlights ReproNovo among privately held, pre-commercial companies selected for innovation, creativity and their potential to [...]
Kraig Biocraft Laboratories Ramps Full Production Across All Three Production Centers as Commercial Deliveries Begin to Take Hold
05/10/2026
Phased Production Model with Staggered Rearing Schedules Keeps Operations Running Continuously, Positioning Kraig Labs to Meet Future Commercial Demand ANN ARBOR, Mich., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Kraig Biocraft [...]
Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
05/10/2026
ATH434 50 mg significantly slowed functional decline in MSA by approximately 52% versus placebo on the 11-item UMSARS at Week 52 with CSF NfL as a covariate Baseline CSF NfL predicted the rate of functional decline, [...]
Invivyd Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
05/10/2026
NEW HAVEN, Conn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Invivyd, Inc. (Nasdaq: IVVD) today announced that on October 1, 2026, Invivyd granted six newly hired non-executive employees options to purchase an aggregate of 157, [...]
Nurix Therapeutics Announces Second Research Term Extension for Oncology Program Under Collaboration with Gilead Sciences
05/10/2026
Two-year extension builds on productive relationship established in 2019 Nurix continues to retain co-development and 50/50 profit sharing options on up to two programs in the United States BRISBANE, Calif., Oct. 05, [...]
Harrow Closes Acquisition of TYRVAYA®
05/10/2026
First and Only FDA-Approved Nasal Spray for Dry Eye Disease Adds a Differentiated, Drop-Free Treatment Option to Harrow’s Growing Ocular Surface Franchise NASHVILLE, Tenn., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Harrow ( [...]
Satellos Granted Composition of Matter Patent for Forazapadin
05/10/2026
Composition of matter provides U.S. protection through Sept. 6, 2044, as forazapadin advances in Phase 2 development TORONTO, Oct. 05, 2026 (GLOBE NEWSWIRE) -- Satellos Bioscience Inc. (NASDAQ: MSLE, TSX: MSCL), a [...]
Rezolute Announces FDA Recommendation to Hold a Pre-BLA Meeting as a Precursor to Submitting a Biologics License Application (BLA) for Congenital Hyperinsulinism
05/10/2026
The Agency reiterated its commitment to addressing the unmet need for treatment of congenital and tumor-related hyperinsulinism and to serving these patient communities On track to report topline results for the Phase 3 [...]
New Pico Laser for Tattoo Removal Includes Installation, On-Site Training and a Two-Year Warranty That Covers Technician Travel
05/10/2026
The PicoTech's two-year warranty covers parts, labor, and shipping or technician travel, the same structure Rock Bottom Lasers uses on the 90-day warranty for its pre-owned equipment. Aesthetika's published [...]
Iridex Completes Relocation of Manufacturing Facility to San Jose, California
05/10/2026
Company Expects to Realize Approximately $600,000 in Annualized Cost Savings SAN JOSE, Calif., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile [...]
Sernova and Seraxis Close US$11.2 Million Financing to Fund Merger to Become BetaNova Biotherapeutics and Advance Type 1 Diabetes Cell Therapy Into Near Term Phase 1/2 Clinical Trial
05/10/2026
TORONTO and GERMANTOWN, Md., Oct. 05, 2026 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics Inc. (“Sernova”) (TSX: SVA) (OTC: SEOVF) (FSE/XETRA: PSHO) and Seraxis Holdings, Inc. (“Seraxis”) today announced the closing of the [...]
Coave Therapeutics Presents Non-Human Primate Data Supporting Lead Wet AMD Gene Therapy Program at Euretina 2026
05/10/2026
New non-human primate data show Coave's ligand-conjugated suprachoroidal vector, coAAV-SCS, achieved up to 120-fold higher retinal and RPE-choroid expression than existing AAV capsids Aflibercept expressed via coAAV-SCS [...]

Pages